Detalhe da pesquisa
1.
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry.
Ann Hematol
; 102(10): 2815-2822, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474632
2.
NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia.
Invest New Drugs
; 39(3): 736-746, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33403501
3.
Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms.
Front Immunol
; 13: 768592, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36211444
4.
A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia.
Med Oncol
; 29(4): 2332-6, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22209840